1. Herzuma 150 mg prašek za koncentrat za raztopino za infundiranje

Herzuma 150 mg prašek za koncentrat za raztopino za infundiranje

Trastuzumab

General information

Drug nameHerzuma 150 mg prašek za koncentrat za raztopino za infundiranje
Medicine nameTrastuzumab
National drug code3000030
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug groupSimilar Biological Medicinal Product
OriginatorNo
Orphan drugNo

Marketing authorization

Procedure typePotrditev podatkov za CP zdravila (modro okence)
No. and date of decision/certificate1024-34/2018-4, 13. 4. 2018
Authorization validity dateUntil further notice
Marketing end date—
Application type—
Authorization/certificate holderCelltrion Healthcare Hungary Kft.

Drug safety monitoring

Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No

ATC codes

LANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01ANTINEOPLASTIC AGENTS
L01FMONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FDHER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
L01FD01trastuzumab

Route of administration

Route of administration name
Intravenska uporaba

Settlement data for compulsory health insurance billing

Substitute medicine

Preparation—
Valid from – to—

Clinical use data

Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo

Shortage actions

Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo

Drug status

Temporary supply disruption of the medicinal product.

Last drug update date:9. 7. 2026
TEST APPLICATION